379 related articles for article (PubMed ID: 21056993)
1. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
[TBL] [Abstract][Full Text] [Related]
2. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
3. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
4. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
6. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
7. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
[TBL] [Abstract][Full Text] [Related]
8. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
10. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
12. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
14. SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer.
Nishimura T; Tamaoki M; Komatsuzaki R; Oue N; Taniguchi H; Komatsu M; Aoyagi K; Minashi K; Chiwaki F; Shinohara H; Tachimori Y; Yasui W; Muto M; Yoshida T; Sakai Y; Sasaki H
Cancer Sci; 2017 Feb; 108(2):216-225. PubMed ID: 27987372
[TBL] [Abstract][Full Text] [Related]
15. SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.
Hong S; Noh H; Teng Y; Shao J; Rehmani H; Ding HF; Dong Z; Su SB; Shi H; Kim J; Huang S
Neoplasia; 2014 Apr; 16(4):279-90.e1-5. PubMed ID: 24746361
[TBL] [Abstract][Full Text] [Related]
16. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
[TBL] [Abstract][Full Text] [Related]
18. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
19. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
20. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
McCoy EL; Iwanaga R; Jedlicka P; Abbey NS; Chodosh LA; Heichman KA; Welm AL; Ford HL
J Clin Invest; 2009 Sep; 119(9):2663-77. PubMed ID: 19726883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
